Core Viewpoint - The Guangzhou Baiyun District is launching a three-year action plan (2026-2028) to accelerate the high-quality development of the biomanufacturing industry, establishing a comprehensive ecosystem to enhance the sector's competitiveness and output [1][2]. Group 1: Action Plan and Ecosystem - The action plan outlines the construction of a "11221" industrial ecosystem, which includes the establishment of 1 biomanufacturing innovation center, 1 pilot base, 2 achievement transformation platforms, two phases of over 1,000 acres of biomanufacturing industrial parks, and a biomanufacturing fund cluster with a scale of 100 billion [1][2]. - The goal is to drive the output value of related biomanufacturing industries to exceed 50 billion by 2028, positioning the area as a leading biomanufacturing hub with national competitiveness [1]. Group 2: Capital and Project Collaboration - A biomanufacturing fund cluster with a total scale of 10 billion has been established, led by Baiyun Investment Group and supported by various top investment institutions and industry leaders, aiming to create a "state-owned enterprise leading + professional fund management + industry enterprise collaboration" structure [2]. - The first phase of the fund has completed a 1 billion fundraising, covering the entire lifecycle of biomanufacturing enterprises from startup to Pre-IPO [2]. Group 3: Project Signings - The event featured significant project signings in areas such as biomedicine, biomaterials, and biocosmetics, including plans for a cell culture medium and CDMO production base by Auscon Biotech, and a core component R&D and production base for mass spectrometers by Shandong Yingsheng Biotech [2]. - Blue Bay Technology will develop a biomanufacturing industrial park that integrates R&D, pilot testing, and production, providing systematic services for technology transformation and enterprise growth [2]. Group 4: Ongoing Support - Guangzhou's municipal departments will continue to support Baiyun District in leveraging its industrial foundation and innovative resources to implement biomanufacturing development policies and facilitate the transformation of more research outcomes [3].